ATOM Fellowship Virtual Information Session 1
The Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium is accepting applications for their Cancer Drug Discovery Data Scientist Fellowship program. This one-year appointment will begin in early 2020 and is based in San Francisco, California. The ATOM Fellowship Program’s goal is to provide both early-career computational and biomedical scientists with an immersive cross-training experience across these disciplines.
This virtual information session will give potential applicants an opportunity to ask questions about the fellowship program and the application process.
To be eligible for the ATOM Fellowship Program, applicants must meet the following criteria:
- Possession of a Ph.D. in Computer Science, Math or Biomedical Science related field from an accredited college or university. Foreign degrees must be evaluated for U.S. equivalency.
- A strong background in any of the following: cancer biology, pharmaceutical or medicinal chemistry, pharmacology, toxicology, drug discovery, computational biology, in silico biology, bioinformatics, systems biology, molecular dynamics, multiscale modeling, machine learning, adaptive learning or high-performance computing.
- Be a U.S. citizen or permanent resident (green card holder).
- Upon selection, one must be able to obtain Public Trust Security Clearance and pass a pre-employment drug screen.
A second session is being offered on October 28, 2019.
- NCI’s New Cancer Moonshot℠ Biobank WebsiteJanuary 27, 2021The Cancer Genomics Cloud: A Secure and Scalable Cloud-Based Platform to Access, Share, and Analyze Multi-Omics Data SetsJanuary 27, 2021Supporting Innovative Cancer Research Through Data PrivacyJanuary 28, 2021Sequence-Structure-Function Modeling for the 3D GenomeJanuary 28, 2021Envisioning the Future of Radiation Oncology Workshop KickoffJanuary 29, 2021